ONDINE BIOMEDICAL INC.CDI (VF5) — Tangible Net Worth Ratio
ONDINE BIOMEDICAL INC.CDI (VF5) has a Tangible Net Worth Ratio of 100.0% as of December 2024. This metric is calculated by deducting intangible assets (€0.00) from net assets (€6.88 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See ONDINE BIOMEDICAL INC.CDI short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ONDINE BIOMEDICAL INC.CDI Tangible Net Worth Ratio (2021–2024)
This chart shows how ONDINE BIOMEDICAL INC.CDI's Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of December 2024, the ratio stands at 100.0%, reflecting net assets of €6.88 Million with intangible assets of €0.00 EUR. See VF5 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for ONDINE BIOMEDICAL INC.CDI (2021–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for ONDINE BIOMEDICAL INC.CDI from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of ONDINE BIOMEDICAL INC.CDI.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | €6.88 Million | €0.00 | €12.82 Million | ▲ +0.0 pp |
| 2023 | 100.0% | €2.08 Million | €0.00 | €5.73 Million | ▲ +0.0 pp |
| 2022 | 100.0% | €11.64 Million | €0.00 | €16.57 Million | ▲ +0.0 pp |
| 2021 | 100.0% | €29.66 Million | €0.00 | €34.14 Million | — |